Medical Treatments for Prostate CancerThere are many different medical treatments for prostate cancer that involve the clinical care of a healthcare professional. These treatments include expectant therapy, surgery, radiation therapy, hormone therapy, and chemotherapy. Expectant therapy is to carefully observe and monitor the prostate cancer. Because prostate cancer cells often spread very slowly, many older men who have the disease may not need more extensive treatment. However, expectant therapy usually includes routine physician examinations, including digital rectal exams and PSA tests. The different types of surgery for prostate cancer are radical prostatectomy - an open-surgery procedure in which the entire prostate gland and surrounding tissue are removed. Transurethral resection of the prostate (TURP) - surgery to remove part of the prostate gland that surrounds the urethra. Cryosurgery - this procedure involves killing the cancer cells by freezing them with a small metal tool placed in the tumor. Side effects of prostate cancer surgery include incontinence and impotence. Incontinence is the inability to control urine and may result in dribbling of urine, especially immediately after surgery. Normal control usually returns within weeks or months after surgery. Impotence is the inability to achieve an erection. For a month, or so, after surgery, most men are not able to get an erection. Eventually, approximately 40 to 60 percent of men will be able to get an erection sufficient for sexual intercourse, but without ejaculation of semen, since removal of the prostate gland prevents that process.Radiation therapy uses high energy rays to kill or shrink cancer cells, and to decrease their ability to divide. Radiation is often used to treat prostate cancer that is still confined to the prostate gland, or has spread only to nearby tissue. If the disease is advanced, radiation may be used to reduce the size of the tumor and to provide relief from symptoms. Possible side effects of radiation for prostate cancer may include diarrhea, with or without blood in the stool, and colitis, problems associated with urination, a degree of impotence (inability to get an erection), which may occur within two years of radiation therapy. The goal of hormone therapy is to lower the level of male hormones in the body, particularly testosterone. Hormone therapy does not cure the cancer, and is often used to treat persons whose cancer has spread or recurred after treatment. Produced mainly in the testicles, testosterone causes prostate cancer cells to grow. Thus, reduced testosterone levels can make the prostate cancer shrink and become less active. Most studies show that hormone therapy works better if it is started early. Chemotherapy is the use of powerful, anti-cancer medications to kill cancer cells.. Hospitalization may be needed to monitor treatment and chemotherapy's side effects. Common side effects of chemotherapy include: nausea and vomiting, hair loss, anemia, reduced ability of blood to clot, mouth sores, increased likelihood of developing infections, fatigue. Most side effects disappear once treatment is stopped. |
| prostate adenocarcinoma staging |
|
CancerGuide: Understanding Cancer Types and Staging Although the trend is towards standard terminology, some types of cancers use staging systems with different nomenclatures. For example, prostate and colon Use of age-specific normal ranges for serum prostate-specific Use of either age-specific normal range would have missed more than 10% of stage II prostate adenocarcinomas in patients over the age of 60 years. Endothelin B receptor gene hypermethylation in prostate adenocarcinoma Prostate adenocarcinoma is the second most common cause of cancer related and each adenocarcinoma was staged and graded according to the TNM staging AmeriPath: Anatomic Pathology Services Prostate Cancer, known as Prostate Adenocarcinoma, is a malignant tumor with prostate cancer ask your physician about the clinical stage of your tumor. Prostatic Neoplasms Clinical Resources Prostate Cancer: Biology, Diagnosis, Pathology, Staging, and Natural History: Prostatic Adenocarcinoma: Access document; Prostate Adenocarcinoma: Access E-Cadherin Expression in Prostate Adenocarcinomas in Chinese and E-Cadherin Expression in Prostate Adenocarcinomas in Chinese and Its Pathological Histological grading and clinical staging of prostatic carcinoma; Three dimensional conformal radiation therapy in prostate In 51 patients with M0 stage adenocarcinoma prostate treated with 3D-CRT, the median age was 68 years. Of the 51 patients, the primary curative treatment in International braz j urol - Prediction of pathological stage in CONCLUSION: the percentage of positive fragments is an independent factor for predicting the pathological stage of prostate adenocarcinoma, and the number IngentaConnect Extended Follow-Up of Patients with Stage T2a Sixty-four patients with Stage T2a prostate adenocarcinoma were identified from the series of prostate patients receiving conformal outpatient brachytherapy Arch Surg -- Abstract: Stage B prostate adenocarcinoma. Flow Over a 16-year period (1966 to 1981), 349 patients underwent radical retropubic prostatectomy for pathologic stage B adenocarcinoma of the prostate. The Journal of Urology : Chromosomal Anomalies in Stage D1 Chromosomal Anomalies in Stage D1 Prostate Adenocarcinoma Primary Tumors and Lymph Node Metastases Detected by Fluorescence in Situ Hybridization Is it necessary to separate clinical stage T1c from T2 prostate CLINICAL STAGES T1C vs T2 PROSTATE ADENOCARCINOMA. ARMATYS. et al. Is it necessary to separate clinical stage T1c from T2. prostate adenocarcinoma? A Novel Biomarker for Staging Human Prostate Adenocarcinoma A Novel Biomarker for Staging Human Prostate Adenocarcinoma: Overexpression of Matriptase with Concomitant Loss of its Inhibitor, Hepatocyte Growth Factor Prostate The prognosis of prostatic adenocarcinoma varies widely with tumor stage and grade. Prostate, adenocarcinoma, immunoperoxidase stain with antibody to PROGENETIX CGH database: Ca: prostate adenoca ProstBiop-rib-10a, Prostate adenocarcinoma stage II, Gleason 7 3 + 4 ProstBiop-rib-13a, Prostate adenocarcinoma stage IV, Gleason 6 3 + 3 eMedicine - Prostate Cancer: Biology, Diagnosis, Pathology Synonyms and related keywords: prostate adenocarcinoma, adenocarcinoma of .. The 2002 TNM staging system is used to stage prostate cancer, as follows: eMedicine - Prostate Carcinoma : Article by Richard Clements Approximately 95% of prostate cancers are adenocarcinomas that develop in the Optimization of prostate carcinoma staging: comparison of imaging and |
| prostate adenocarcinoma staging |
|
new prostate cancer test prostate cancer lycopene incontinence after prostate laparoscopic prostatectomy technique |